Rare Infectious Disease News
Spotlight On
Cat scratch disease
Cat scratch disease is a bacterial infection caused by Bartonella henselae bacteria
Prevelance
1-9 / 100 000
Age of Onset
ICD-10
A28.1
Inheritance
Autosomal dominant
Autosomal recessive
Mitochondrial/Multigenic
X-linked dominant
X-linked recessive
5 Facts you should know
FACT
CSD is bacterial infection that primarily affects the lymph nodes
FACT
It is typically caused by the bacteria bartonella (Bartonella henselae)
FACT
It is usually transmitted by being scratched or bitten by a cat, but rarely, no scratch or bite is involved
FACT
Symptoms typically begin within 3–14 days following infection
FACT
In most patients the disease resolves spontaneously within 2-4 months without treatment
Interest over time
Google searches
Common signs & symptoms
Most people with cat scratch disease have been bitten or scratched by a cat and develop a mild infection at the point of injury within about 3-14 days. The infected area may be warm and painful and may appear appear swollen and red with round, raised lesions. Lymph nodes, especially those around the head, neck, and upper limbs, become swollen.[2] Additionally, a person with cat scratch disease may experience fever, headache, fatigue, achiness and discomfort (malaise), sore throat, enlarged spleen, and/or loss of appetite.[3][4][2]
Top Clinical Trials
| Title | Description | Phases | Status | Interventions | More Information |
|---|---|---|---|---|---|
| Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis (BIGG) (Trial in France) | Double blind controlled study versus placebo. Patients with suppurated CSD's lymphadenitis will receive immediately after the pus aspiration (performed for a diagnostic purpose) an intra-nodal injection of gentamicin or of placebo (NaCl 0,9%) and be treated with oral azithromycin for 5 days. | Phase 3 | Recruiting | Drugs: gentamicin, azithromycin. Drug: placebo | Click here for more information |
Top Treatments in Research
| Agent | Class/Mechanism of Action | Development Status | Company | Clinical Studies | More Information |
|---|---|---|---|---|---|
| gentamycin | Aminoglycoside | Phase 3 | University Hospital, Toulouse | Click here for more information | Click here for more information |